Aptamer Group PLC (AIM:APTA)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.2850
0.00 (0.00%)
Nov 5, 2026, 3:43 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 9.85 million as of November 5, 2026. It is the 40,005th most valuable company in the world and the 880th biggest in the United Kingdom. Its market cap has decreased by 55.74% in one year.
Market Cap
9.85M
Enterprise Value
5.66M
Revenue
1.54M
Global Rank
Country Rank
#880 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 9.85M, a decrease of -89.91%. That is a compound annual growth rate of -37.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 9.85M | -66.04% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 13.44M |
| SkinBioTherapeutics | 13.02M |
| Genflow Biosciences | 10.31M |
| Thalia Therapeutics | 9.78M |
| Palatin Technologies | 7.26M |
| Fusion Antibodies | 7.26M |
| CRISM Therapeutics | 6.73M |
| Solvonis Therapeutics | 6.30M |